I think SP will increase independently of any one treatment. Now that the company is on the radar people will invest in the company, not the drug. A lot of new holders know nothing about Monepantel, they just know the company's doing well.
Ann: Investor webinar - Phase 1 MND Study Top-Line Results, page-68
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.8¢ |
Change
-0.003(1.47%) |
Mkt cap ! $80.25M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $57.91K | 343.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19999 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.32pm 18/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |